Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
pmc-release:
01
09
2024
medline:
16
8
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
ppublish
Résumé
Infectious disease exposures in early life are increasingly recognized as a risk factor for poor subsequent growth and neurodevelopment. We aimed to evaluate the association between cumulative illness with neurodevelopment and growth outcomes in a birth cohort of Guatemalan infants. From June 2017 to July 2018, infants 0-3 months of age living in a resource-limited region of rural southwest Guatemala were enrolled and underwent weekly at-home surveillance for caregiver-reported cough, fever, and vomiting/diarrhea. They also underwent anthropometric assessments and neurodevelopmental testing with the Mullen Scales of Early Learning (MSEL) at enrollment, 6 months, and 1 year. Of 499 enrolled infants, 430 (86.2%) completed all study procedures and were included in the analysis. At 12-15 months of age, 140 (32.6%) infants had stunting (length-for-age Z [LAZ] score < -2 SD) and 72 (16.7%) had microcephaly (occipital-frontal circumference [OFC] < -2 SD). In multivariable analysis, greater cumulative instances of reported cough illness (beta = -0.08/illness-week, P = 0.06) and febrile illness (beta = -0.36/illness-week, P < 0.001) were marginally or significantly associated with lower MSEL Early Learning Composite (ELC) Score at 12-15 months, respectively; there was no association with any illness (cough, fever, and/or vomiting/diarrhea; P = 0.27) or with cumulative instances of diarrheal/vomiting illness alone ( P = 0.66). No association was shown between cumulative instances of illness and stunting or microcephaly at 12-15 months. These findings highlight the negative cumulative consequences of frequent febrile and respiratory illness on neurodevelopment during infancy. Future studies should explore pathogen-specific illnesses, host response associated with these syndromic illnesses, and their association with neurodevelopment.
Sections du résumé
BACKGROUND
Infectious disease exposures in early life are increasingly recognized as a risk factor for poor subsequent growth and neurodevelopment. We aimed to evaluate the association between cumulative illness with neurodevelopment and growth outcomes in a birth cohort of Guatemalan infants.
METHODS
From June 2017 to July 2018, infants 0-3 months of age living in a resource-limited region of rural southwest Guatemala were enrolled and underwent weekly at-home surveillance for caregiver-reported cough, fever, and vomiting/diarrhea. They also underwent anthropometric assessments and neurodevelopmental testing with the Mullen Scales of Early Learning (MSEL) at enrollment, 6 months, and 1 year.
RESULTS
Of 499 enrolled infants, 430 (86.2%) completed all study procedures and were included in the analysis. At 12-15 months of age, 140 (32.6%) infants had stunting (length-for-age Z [LAZ] score < -2 SD) and 72 (16.7%) had microcephaly (occipital-frontal circumference [OFC] < -2 SD). In multivariable analysis, greater cumulative instances of reported cough illness (beta = -0.08/illness-week, P = 0.06) and febrile illness (beta = -0.36/illness-week, P < 0.001) were marginally or significantly associated with lower MSEL Early Learning Composite (ELC) Score at 12-15 months, respectively; there was no association with any illness (cough, fever, and/or vomiting/diarrhea; P = 0.27) or with cumulative instances of diarrheal/vomiting illness alone ( P = 0.66). No association was shown between cumulative instances of illness and stunting or microcephaly at 12-15 months.
CONCLUSIONS
These findings highlight the negative cumulative consequences of frequent febrile and respiratory illness on neurodevelopment during infancy. Future studies should explore pathogen-specific illnesses, host response associated with these syndromic illnesses, and their association with neurodevelopment.
Identifiants
pubmed: 37343218
doi: 10.1097/INF.0000000000004006
pii: 00006454-202309000-00002
pmc: PMC10527407
mid: NIHMS1907028
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
739-744Subventions
Organisme : NIAID NIH HHS
ID : 75N93021C00012
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201300015I
Pays : United States
Organisme : NIAID NIH HHS
ID : K23 AI143967
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001082
Pays : United States
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Lancet. 2017 Jan 7;389(10064):77-90
pubmed: 27717614
Lancet Glob Health. 2019 Oct;7(10):e1398-e1413
pubmed: 31537370
PLoS Negl Trop Dis. 2018 May 29;12(5):e0006363
pubmed: 29813057
Child Care Health Dev. 2020 May;46(3):327-335
pubmed: 31978249
Adv Nutr. 2019 Mar 1;10(2):196-204
pubmed: 30801614
J Child Psychol Psychiatry. 2017 Nov;58(11):1264-1275
pubmed: 28543426
Pediatrics. 2010 Jul;126(1):e26-32
pubmed: 20595453
Child Care Health Dev. 2019 Sep;45(5):702-708
pubmed: 31270836
Pediatr Infect Dis J. 2018 Apr;37(4):e107-e108
pubmed: 28858041
Glob Health Sci Pract. 2017 Dec 28;5(4):686-696
pubmed: 29284702
Int J Equity Health. 2019 Jul 18;18(1):110
pubmed: 31319862
Curr HIV/AIDS Rep. 2019 Dec;16(6):501-513
pubmed: 31732866
Matern Child Nutr. 2020 Jan;16(1):e12864
pubmed: 31237738
Dev Cogn Neurosci. 2022 Feb;53:101041
pubmed: 34973509
PLoS Negl Trop Dis. 2022 Nov 16;16(11):e0010480
pubmed: 36383617
BMJ Glob Health. 2019 Jan 13;4(1):e001155
pubmed: 30775005
Annu Rev Psychol. 2015 Jan 3;66:433-57
pubmed: 25196276
Lancet Glob Health. 2017 Feb;5(2):e217-e228
pubmed: 28104188
Adv Nutr. 2019 Jul 1;10(4):725-726
pubmed: 31041450
J Nutr. 2018 Aug 1;148(8):1364-1371
pubmed: 30011008
Public Health Nutr. 2015 Jul;18(10):1737-45
pubmed: 26017476
Influenza Other Respir Viruses. 2022 Jan;16(1):101-112
pubmed: 34519426
J Dev Orig Health Dis. 2022 Dec;13(6):779-786
pubmed: 35450541
Ann Glob Health. 2020 Feb 03;86(1):8
pubmed: 32064226
Am J Clin Nutr. 2014 Dec;100(6):1644S-51S
pubmed: 25411307
Am J Trop Med Hyg. 2017 Sep;97(3):944-948
pubmed: 28722580
Viruses. 2021 Dec 18;13(12):
pubmed: 34960812
Pediatrics. 2017 Apr;139(Suppl 1):S12-S22
pubmed: 28562245
Adv Pediatr. 2016 Aug;63(1):357-87
pubmed: 27426907
Am J Gastroenterol. 2022 Jan 1;117(1):167-175
pubmed: 34693912
BMC Pediatr. 2014 Feb 18;14:50
pubmed: 24548288
Am J Trop Med Hyg. 2017 Sep;97(3):974-979
pubmed: 28722635
Arch Dis Child. 2023 Apr;108(4):287-288
pubmed: 35074831
J Med Internet Res. 2017 Nov 09;19(11):e368
pubmed: 29122738
Emerg Infect Dis. 2022;28(13):S277-S287
pubmed: 36502430
PLoS One. 2012;7(10):e47908
pubmed: 23118906